Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

NCT04772443 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: DWJ1506
DRUG: DWJ1507
DRUG: DWC202011
DRUG: DWJ1177

Sponsor

Daewoong Pharmaceutical Co. LTD.